Acerta Pharma B.V. et al v. MSN Pharmaceuticals Inc., et al.

1:2022-cv-00163
ANDA
Bio-Tech
Cause of ActionLogin To View
Appeal NumberLogin To View
StatusLogin To View
OutcomeSubscription-Only
Patent
7
07459554092905041027208310239883
Filing DateFeb 4, 2022
Termination DateLogin To View
CourtLogin To View
JudgesLogin To View
Case LengthLogin To View
Technology Center-
Plaintiff
2
Astrazeneca
Merck & Co. Inc.
Defendant
1
Msn Laboratories
ANDA report image

Empower your practice with Patexia ANDA IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a ANDA Attorney & Experts?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.